Bruker Co. (BRKR) Receives Average Rating of “Hold” from Analysts
Bruker Co. (NASDAQ:BRKR) has received an average rating of “Hold” from the sixteen ratings firms that are presently covering the firm, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $28.90.
A number of equities research analysts have recently weighed in on the company. BidaskClub downgraded Bruker from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Goldman Sachs Group reiterated a “sell” rating and issued a $24.00 price target on shares of Bruker in a report on Tuesday, September 26th. J P Morgan Chase & Co upgraded Bruker from an “underweight” rating to a “neutral” rating and set a $28.00 price target for the company in a report on Friday, November 3rd. Citigroup boosted their price target on Bruker from $29.00 to $34.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. Finally, Cowen restated a “hold” rating and set a $29.00 price objective on shares of Bruker in a research note on Friday, November 3rd.
In other Bruker news, VP Mark Munch sold 21,061 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $29.97, for a total transaction of $631,198.17. Following the completion of the transaction, the vice president now owns 60,524 shares in the company, valued at approximately $1,813,904.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 35.20% of the company’s stock.
Bruker (BRKR) traded up $0.05 during mid-day trading on Thursday, reaching $35.18. The company’s stock had a trading volume of 729,903 shares, compared to its average volume of 631,908. Bruker has a 52 week low of $21.03 and a 52 week high of $36.53. The company has a quick ratio of 1.60, a current ratio of 2.60 and a debt-to-equity ratio of 0.65. The stock has a market cap of $5,470.00, a P/E ratio of 31.07, a PEG ratio of 3.07 and a beta of 1.05.
Bruker (NASDAQ:BRKR) last issued its quarterly earnings results on Thursday, November 2nd. The medical research company reported $0.29 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.27 by $0.02. Bruker had a return on equity of 25.83% and a net margin of 8.85%. The business had revenue of $435.60 million during the quarter, compared to the consensus estimate of $415.45 million. During the same period in the previous year, the business earned $0.32 EPS. The business’s quarterly revenue was up 10.6% on a year-over-year basis. equities research analysts anticipate that Bruker will post 1.19 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 22nd. Shareholders of record on Monday, December 4th will be given a dividend of $0.04 per share. The ex-dividend date of this dividend is Friday, December 1st. This represents a $0.16 dividend on an annualized basis and a yield of 0.45%. Bruker’s dividend payout ratio (DPR) is presently 17.02%.
Bruker Company Profile
Bruker Corporation designs and manufactures scientific instruments, and analytical and diagnostic solutions. Its segments include the Bruker BioSpin Group; the Bruker Chemicals, Applied Markets, Life Science, In-Vitro Diagnostics, Detection (CALID) Group; the Bruker Nano Group, and the Bruker Energy & Supercon Technologies (BEST) Segment.
Receive News & Ratings for Bruker Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker Co. and related companies with MarketBeat.com's FREE daily email newsletter.